First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and ...

Results at Six Months VCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the ...

Field Medical, Inc., a leader in pulsed field ablation (PFA) technology for ventricular tachycardia (VT), today announced its participation at the 20th Annual International Symposium on Ventricular ...

MADRID -- For patients with cardiovascular disease, efforts to raise potassium levels paid off in terms of a reduction in the risk of ventricular arrhythmias in the POTCAST randomized trial. High-risk ...